TPST
Tempest Therapeutics, Inc.
-0.31 (-25.75%)0.90USD5.7M成交股數13.3M市值–本益比(近四季)45.1股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.8M | 114K | 538K | 570K | 3.9M | 7.6M | 7.6M | 5.8M | 4.3M | 4.2M | 4.2M | 4.4M |
| 銷售管理費用 | 3.4M | 5.4M | 3.5M | 3.0M | 4.1M | 3.3M | 3.0M | 3.7M | 3.6M | 3.3M | 2.4M | 3.1M |
| 營業利益 | −5.3M-34% | −27.7M+153% | −4.1M-61% | −3.6M-62% | −8.0M-0% | −10.9M+46% | −10.6M+60% | −9.6M+28% | −8.0M | −7.5M | −6.6M | −7.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −5.2M-33% | −27.7M+155% | −4.0M-62% | −3.5M-63% | −7.9M-0% | −10.9M+45% | −10.6M+56% | −9.6M+26% | −7.9M | −7.5M | −6.8M | −7.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.34-84% | -2.53-20% | -0.31-94% | -0.79-86% | -2.07-55% | -3.16+829% | -5.32+1008% | -5.52+922% | -4.62 | -0.34 | -0.48 | -0.54 |
| 稀釋股數 | 15.2M | 10.9M | 4.1M | 4.4M | 3.8M | 3.4M | 2.0M | 1.7M | 1.7M | 15.4M | 14.1M | 14.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 779K | 1.8M | 7.7M | 7.5M | 14.3M | 21.5M | 22.1M | 31.1M | 32.3M | 39.2M | 11.1M | 17.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 9.6M | 10.7M | 16.9M | 17.1M | 24.5M | 32.2M | 33.8M | 42.2M | 44.4M | 51.6M | 24.0M | 30.7M |
| 有息負債 | – | – | – | – | – | 4.2M | 0 | 2.0M | 4.1M | 6.3M | 8.4M | 7.5M |
| 總負債 | 10.7M | 9.9M | 10.3M | 10.8M | 14.7M | 21.0M | 22.4M | 25.2M | 23.7M | 24.8M | 25.2M | 25.7M |
| 股東權益 | −1.1M | 822K | 6.7M | 6.3M | 9.8M | 11.1M | 11.5M | 16.9M | 20.6M | 26.8M | −1.2M | 5.0M |
| 負債比 | 111.3% | 92.4% | 60.6% | 63.0% | 60.0% | 65.4% | 66.1% | 59.8% | 53.5% | 48.1% | 105.0% | 83.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | 17.3M | 22.1M | 29.1M | 28.2M | 33.0M | 2.7M | 10.1M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −7.6M-5% | – | – | – | −8.0M | – | – | −7.2M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 0 | – | – | 168K | – | – | – |
| 自由現金流 | – | −7.6M-5% | – | – | – | −8.0M | – | – | −7.4M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −26.3M | –% | -6.33 | −26.8M |
| FY2024 | – | – | −41.8M | –% | -19.50 | −33.5M |
| FY2023 | – | – | −29.5M | –% | -1.91 | −27.5M |
| FY2022 | – | – | −35.7M | –% | -3.09 | −31.6M |
| FY2021 | – | – | −28.3M | –% | -7.47 | −26.1M |
| FY2020 | – | – | −19.2M | –% | -41.03 | −19.1M |
| FY2019 | – | – | −44.6M | –% | -3.25 | −41.6M |
| FY2018 | – | – | −27.2M | –% | -17.58 | −23.7M |